Funding for this research was provided by:
Natural Science Foundation of Guangdong Province (2016A030313010, 2018A030313506)
The Basic Research Project of Science and Innovation Commission of Shenzhen (JCYJ20160429185525629)
Natural Science Foundation of Shenzhen University General Hospital (0000040558)
Received: 5 February 2019
Revised: 24 April 2019
Accepted: 10 May 2019
First Online: 31 May 2019
Ethics approval and consent to participate
: The study was authorized by the Institutional Review Board and Ethics Committee of the University of Hong Kong-Shenzhen Hospital. The enrolled patients in this study were provided with informed consent. The Institutional Review Board and Ethics Committee approved for the differentiation of PGCs from a human pluripotent stem cell. The teratoma experiments in our study were conformed to the national guidelines and were authorized by the institutional review board.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.